They not only enhance tumor suppression by activating cytotoxic CD8+ T cells but can also directly contribute to tumor eradication through certain effector subsets (Yang et al., 2020; Noor et al., 2024; Sacher et al., 2020). The gene discussed is CD8A; the disease is neoplasm.